Faculty Focus

The Kraft Precision Medicine Accelerator was established with an endowment from the Robert and Myra Kraft Family Foundation. Led by a diverse team of health care and business visionaries, the Accelerator leverages unique resources and world-renowned faculty. Kathy Giusti and Richard Hamermesh; co-chairs of the Kraft Precision Medicine Accelerator. 
BLAVATNIK FELLOWSHIP IN LIFE SCIENCE ENTREPRENEURSHIP is led by Professor Peter Barrett, and provides a select group of alumni with the opportunity to work with Harvard inventors to promote the commercialization of life science technologies with significant market potential. Fellows are part of the HBS Health Care Initiative and the vibrant entrepreneurial community at Harvard.

Featured Research

  • 21 Mar 2019
  • Working Knowledge

Advancing Computational Biology and Bioinformatics Research Through Open Innovation Competitions

by Blasco, Andrea, Michael G. Endres, Rinat A. Sergeev, Anup Jonchhe, Max Macaluso, Rajiv Narayan, Ted Natoli, Jin H. Paik, Bryan Briney, Chunlei Wu, Andrew I. Su, Aravind Subramanian, and Karim R. Lakhani
  • 15 Mar 2019
  • Science

Targeting cancer and careers: Precision Medicine

Re: Richard Hamermesh
  • August 2018
  • Review of Industrial Organization

The Impact of the Entry of Biosimilars: Evidence from Europe

By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
  • 30 Mar 2017
  • Harvard Business School

Public Funding Essential for Advances in Biomedical Research

Re: Danielle Li

MBA Course

Lab to Market: Field Course

The Lab to Market field course outlines the path from embryonic discoveries made in R&D labs to their development for commercial use and onwards to market launch. The course is designed for students who either want to start businesses that have science and technology intellectual property at their core or anticipate leading market launch teams in incumbent organizations.

Executive Education

Accelerating Innovation in Precision Medicine

Precision medicine has the potential to transform how we treat or even cure cancer and other genetic diseases.This program strives to address this problem by convening leaders from the scientific, medical, technological, and business communities to explore business models in precision medicine — also known as personalized medicine — and work together to accelerate progress in this burgeoning area.

Leading an Enduring Science-Based Business

Leaders of life science businesses are facing mounting pressures both externally and internally. The once-sharp delineation between the worlds of science, medicine, and business has blurred. Advances in science not only change the way scientists work, they also change the way science-based organizations are managed, funded, and commercialized. Likewise, management and business practices not only affect what science is done, but also how it is done. Participants will leave this program better prepared to work collaboratively across functions to build an enduring science-based business.